Evidence-Based Medicine Guidelines
Cholinesterase inhibitors for Lewy body dementia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cholinesterase Inhibitors for Lewy Body Dementia." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455795/all/Cholinesterase_inhibitors_for_Lewy_body_dementia.
Cholinesterase inhibitors for Lewy body dementia. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/455795/all/Cholinesterase_inhibitors_for_Lewy_body_dementia. Accessed December 8, 2024.
Cholinesterase inhibitors for Lewy body dementia. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455795/all/Cholinesterase_inhibitors_for_Lewy_body_dementia
Cholinesterase Inhibitors for Lewy Body Dementia [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 December 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455795/all/Cholinesterase_inhibitors_for_Lewy_body_dementia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cholinesterase inhibitors for Lewy body dementia
ID - 455795
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455795/all/Cholinesterase_inhibitors_for_Lewy_body_dementia
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
